Ensysce Biosciences Statistics
NASDAQ: ENSCHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.458+0.0286 (+6.66%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Pre-market: 0.4451 -2.82%
Ensysce Biosciences by the numbers
Ensysce Biosciences has a market capitalization of $8.9 million based on 19.46M shares outstanding. With trailing EPS of $-2.47, Ensysce Biosciences is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 10.8% above its 50-day average and 3.2% below its 200-day average.
Average daily trading volume is 14.21M shares, or about $6.5 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ENSC valuation vs. peer median
| Metric | ENSC | Peer median | Difference |
|---|---|---|---|
| Market cap | $8.91M | $8.73M | +2% |
| Avg. volume | 14.21M | 1.48M | +857% |
Peer median across 8 companies: CALC, IMRN, MTVA, JAGX, MBRX, APUS, AZTR, CNSP.
Valuation
- Market cap
- $8.91M
- EPS (TTM)
- $-2.47
- Shares outstanding
- 19.46M
Price and trading
- Previous close
- 0.4294
- Open
- 0.439
- Day range
- 0.4014 – 0.4743
- 52-week range
- 0.23 – 2.75
- 50-day moving average
- 0.4132
- 200-day moving average
- 0.4732
- Beta
- —
- Volume
- 1.26M
- Average volume
- 14.21M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 14, 2025
Additional statistics
- Market Cap
- 8.91M
- Forward Pe
- -9.16
- Eps
- -2.47
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 2.75
- Week52 Low
- 0.23
- Avg Volume
- 14.21M
- Shares Outstanding
- 19.46M
- Ma50
- 0.41
- Ma200
- 0.47
- Earnings Date
- Aug 14, 2025
- Pct From52w High
- -83.35%
- Pct From52w Low
- 99.13%